SEARCH

SEARCH BY CITATION

References

  • 1
    Kiess W, Greenstein LA, White RM, Lee L, Rechler MM, Nissley SP. Type II insulin-like growth factor receptor is present in rat serum. Proc Natl Acad Sci U S A 1987; 84: 77207724.
  • 2
    Causin C, Waheed A, Braulke T, Junghans U, Maly P, Humbel RE, Figura KV. Mannose 6-Phosphate/insulin-like growth factor -II binding proteins in human serum and urine. Biochem J 1988; 252: 795799.
  • 3
    MacDonald RG, Tepper MA, Clairmont KB, Perregaux SB, Czech MP. Serum form of the rat insulin-like growth factor-II/mannose 6-phosphate receptor is truncated in the carboxylterminal domain. J Biol Chem 1989; 264: 32563261.
  • 4
    Kovacina KS, Steele-Perkins G, Purchio AF, Lioubin M, Miyazono K, Heldin C, Roth RA. Interactions of recombinant and platelet transforming growth factor-β1 precursor with the insulin-like growth factor-II/mannose 6-phosphate receptor. Biochem Biophys Res Commun 1989; 160: 393403.
  • 5
    Lee S, Nathans D. Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors. J Biol Chem 1988; 263: 35213527.
  • 6
    Dahms NM, Lobel P, Kornfeld S. Mannose 6-phosphate receptors and lysosomal enzyme targeting. J Biol Chem 1989; 264: 1211512118.
  • 7
    Clairmont KB, Czech MP. Extracellular release as the major degradative pathway of the insulin-like growth factor-II/mannose 6-phosphate receptor. J Biol Chem 1991; 266: 1213112134.
  • 8
    Bobek G, Scott CD, Baxter RC. Radioimmunoassay of Soluble Insulin-like Growth Factor-II/Mannose 6-Phosphate Receptor: Developmental Regulation of Receptor Release by Rat Tissues in Culture. Endocrinology 1992; 130: 33873394.
  • 9
    De Bleser PJ, Jannes P, van Buul-Offers SC, Hoogerbrugge CM, van Schravendijk CFH, Niki T, Rogiers V, et al. Insulin-like growth factor-II/mannose 6-phosphate receptor is expressed on CCl4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-β in cocultures with sinusoidal endothelial cells. Hepatology 1995; 21: 14291437.
  • 10
    Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor β: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 1990; 11: 599605.
  • 11
    Davis BH. Transforming growth factor beta responsiveness is modulated by the extracellular collagen matrix during hepatic Ito cell culture. J Cell Physiol 1988; 136: 547553.
  • 12
    Matsuoka M, Pham N, Tsukamoto H. Different effects of interleukin-1 α, tumor necrosis factor α, and transforming growth factor β 1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver 1989; 9: 7178.
  • 13
    Czaja MJ, Weiner FR, Flanders KG, Giambrone M, Wind R, Biempica L, Zern MA. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol 1989; 108: 24772482.
  • 14
    Tsutsumi Y, Kakumu S, Yoshioka K, Aroa M, Inoue M, Wakita T. Effects of various cytokines on collagen synthesis by normal rat hepatocytes in primary cultures and fibroblasts. Digestion 1989; 44: 191199.
  • 15
    Meyer DH, Bachem MG, Gressner AM. Transformed fat storing cells inhibit the proliferation of cultured hepatocytes by secretion of transforming growth factor beta. J Hepatol 1990; 11: 8691.
  • 16
    Castilla A, Prieto J, Fausto N. Transforming growth factors β1 and α in chronic liver disease. N Engl J Med 1991; 324: 933940.
  • 17
    Dennis PA, Rifkin DB. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci U S A 1991; 88: 580584.
  • 18
    Jirtle RL, Carr BI, Scott CD. Modulation of insulin-like growth factor-II/mannose 6-phosphate receptors and transforming growth factor-β1 during liver regeneration. J Biol Chem 1991; 266: 2244422450.
  • 19
    Saperstein LA, Jirtle RL, Farouk M, Thompson HJ, Chung KS, Meyers WC. Transforming growth factor-β1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Hepatology 1994; 19: 412417.
  • 20
    De Bleser P, Geerts A, Van Eyken P, Vrijsen R, Lazou J, Desmet V, Wisse E. Tenascin synthesis in cultured rat liver fat-storing cells. In: WisseE, KnookD, McCuskeyR, eds. Cells of the hepatic sinusoid. Rijswijk: Kupffer Cell Foundation, 1991: 218221.
  • 21
    Chomszynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156159.
  • 22
    Geerts A, Greenwel P, Cunningham M, De Bleser P, Rogiers V, Wisse E, Rojkind M. Identification of connective tissue gene transcripts in freshly isolated parenchymal, endothelial, Kupffer and fat-storing cells by Northern hybridization analysis. J Hepatol 1993; 19: 148158.
  • 23
    Scott CD, Baxter RC. Purification and Immunological Characterization of the Rat Liverlnsulin-like Growth Factor-II Receptor. Endocrinology 1987; 120: 19
  • 24
    Laemmli UK Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970; 227: 680685.
  • 25
    Geerts A, Vrijsen R, Rauterberg J, Burt A, Schellinck P, Wisse E. In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion. J Hepatol 1989; 9: 5968.
  • 26
    Mak KM, Lieber CS. Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology 1988; 8: 10271033.
  • 27
    French SW, Myamoto K, Wong K, Jui L, Briere L. Role of the Ito cells in liver parenchymal fibrosis in rats fed alcohol and a high fat-low protein diet. Am J Pathol 1988; 132: 7385.
  • 28
    Mak KM, Leo MA, Lieber CS. Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells. Gastroenterology 1984; 87: 188200.
  • 29
    McGee JOD, Patrick RS. The role of perisinusoidal cells in hepatic fibrogenesis: an electron microscopic study of acute carbon tetrachloride liver injury. Lab Invest 1972; 26: 429440.
  • 30
    Horn T, Junge J, Christoffersen P. Early alcoholic liver injury: activation of lipocytes in acinar zone 3 and correlation to degree of collagen formation in the Disse space. J Hepatol 1986; 3: 333340.
  • 31
    Yokoi Y, Namihisa T, Kuroda H, Komatsu I, Miyazaki A, Watanabe S, Usui K. Immunocytochemical detection of desmin in fatstoring cells (Ito cells). Hepatology 1984; 4: 709714.
  • 32
    Takase S, Leo MA, Nouchi T, Lieber CS. Desmin distinguishes cultured fat-storing cells from myofibroblasts, smooth muscle cells and fibroblasts in the rat. J Hepatol 1988; 6: 267276.
  • 33
    Rojkind M, Greenwel P. The liver as a bioecological system. In: AriasIM, JakobyWB, PopperH, SchachterD, ShafritzDA, eds. The liver: biology and pathobiology. New York: Raven, 1988: 12691285.
  • 34
    Armendariz-Borunda J, Katai H, Jones CM, Seyer JM, Kang AH, Raghow R. Transforming growth factor β gene expression is transiently enhanced at a critical stage during liver regeneration after CCl4 treatment. Lab Invest 1993; 69: 283294.
  • 35
    Fernandez-Botran R. Soluble cytokine receptors: their role in immunoregulation. FASEB J 1991; 5: 25672574.
  • 36
    Pui C, Ip SH, Iflah S, Behm FG, Grose BH, Dodge RK, Crist WM, et al. Serum interleukin 2 receptor levels in childhood acute lymphoblastic leukemia. Blood 1988; 71: 11351137.
  • 37
    Semenzato G, Foa R, Agostini C, Zambello R, Trentin L, Vinante F, Benedetti F, et al. High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia. Blood 1987; 70: 396400.
  • 38
    Symons JA, Wood NC, Giovine FSD, Duff GW. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol 1988; 141: 26122618.
  • 39
    Greenberg SJ, Marcon L, Hurwitz BJ, Waldmann TA, Nelson DL. Elevated levels of soluble interleukin-2 receptors in multiple sclerosis. N Engl J Med 1988; 319: 10191020.
  • 40
    Honda M, Kitamura K, Matsuda K, Yokota Y, Yamamoto N, Mitsuyasu R, Chermann J, et al. Soluble IL-2 receptor in AIDS. Correlation of its serum level with the classification of HIV-induced diseases and its characterization. J Immunol 1989; 142: 42484255.